Washington, D.C. 20549


FORM 12b-25



SEC FILE NO.   333-213009

CUSIP NUMBER   13767A103







[  ] Form 10-K [  ] Form 20-F [  ] Form 11-K [x] Form 10-Q [  ]Form 10-D

[  ] Form N-SAR [  ] Form N-CSR




For Period Ended: February 28, 2020




[  ] Transition Report on Form 10-K


[  ] Transition Report on Form 20-F


[  ] Transition Report on Form 11-K


[  ] Transition Report on Form 10-Q


[  ] Transition Report on Form N-SAR




For the Transition Period Ended:





Read Instruction Before Preparing Form. Please Print or Type.

Nothing in this form shall be construed to imply that the Commission has verified any information contained herein. 


If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates:







Full Name of Registrant:

Cannabis Suisse Corp.


Former Name if Applicable: Geant Corp.



Address of Principal Executive Office (Street and Number)(Zip Code)

Lerzenstrasse 12, Dietikon, Switzerland, 8953




PART II  RULES 12b-25(b) AND (c)


If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the following should be completed. (Check box if appropriate)







The reason described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense;






The subject annual report, semi-annual report, transition report on Form 10-K, Form 20-F, Form 11-K, Form N-SAR or Form N-CSR, or portion thereof, will be filed on or before the fifteenth calendar day following the prescribed due date; or the subject quarterly report or transition report on Form 10-Q or subject distribution report on Form 10-D, or portion thereof, will be filed on or before the fifth calendar day following the prescribed due date; and






The accountants statement or other exhibit required by Rule 12b-25(c) has been attached if applicable.







Cannabis Suisse Corp. (the Company) is filing this Notification of Late Filing on Form 12b-25 with respect to its Quarterly Report on Form 10-Q for the fiscal quarter ended February 29, 2020 (the Form 10-Q). The Company is currently not able to file its Form 10-Q by the prescribed deadline due to the delays and complications caused by the COVD-19 pandemic. The Company is planning to file the Quarterly Report as soon as practicable. The Company estimates to be able to complete it within the extension period of five calendar days provided under Rule 12b-25 of the Securities Exchange Act, as amended.












Name and telephone number of persons to contact in regard to this notification










Suneetha Nandana Silva Sudusinghe







(Area Code)


(Telephone Number)



Have all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file such report(s) been filed? If answer is no, identify report(s). 


[x] Yes [  ] No









Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof? 

[  ] Yes [x] No









The statements included in this Form 12b-25 regarding our financial performance and results of operations, in each case as expected to be reported and other statements that are not historical facts are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Although we believe the expectations and forecasts reflected in our forward-looking statements are reasonable, we can give no assurance they will prove to have been correct. They can be affected by inaccurate assumptions or by known or unknown risks and uncertainties. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those indicated. Factors that could cause actual results to differ materially from expected results include the results and finalization of the Companys financial statements, audit and reviews and those described under Risk Factors in our most recent Form 10-K and other filings with the U.S. Securities and Exchange Commission.





Cannabis Suisse Corp.

(Name of Registrant as Specified in Charter) 


has caused this notification to be signed on its behalf by the undersigned hereunto duly authorized.










Date: June 1, 2020                                                                                                          


/s/    Suneetha Nandana Silva Sudusinghe




Suneetha Nandana Silva Sudusinghe

Chief Executive Officer